Back
Corvus Pharmaceuticals Stock Price Chart
This Tech Company Grew 32,481%...
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
39
CRVS
Corvus Pharmaceuticals
Last Price:
$4.13
Seasonality Move:
5.66%
7 Day Trial
ALL ACCESS PASS
$
7
-
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and CRVS is experiencing buying pressure, which is a positive indicator for future bullish movement.
Corvus Pharmaceuticals Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 3.71 | Buy |
| 20-day SMA: | 3.68 | Buy |
| 50-day SMA: | 3.48 | Buy |
| 200-day SMA: | 5.29 | Sell |
| 8-day EMA: | 3.78 | Buy |
| 20-day EMA: | 3.66 | Buy |
| 50-day EMA: | 3.11 | Buy |
| 200-day EMA: | 1.4 | Buy |
Corvus Pharmaceuticals Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.16 | Buy |
| Relative Strength Index (14 RSI): | 60.53 | Buy |
| Chaikin Money Flow: | 807143 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (3.41 - 3.91) | Buy |
| Bollinger Bands (100): | (3.34 - 5) | Sell |
Corvus Pharmaceuticals Technical Analysis
| May 19 | May 20 | May 21 | May 22 | May 23 | May 27 | May 28 | May 29 | May 30 | Jun 2 | |
|---|---|---|---|---|---|---|---|---|---|---|
| May | ||||||||||
| 19 | 20 | 21 | 22 | 23 | 27 | 28 | 29 | 30 | 02 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Corvus Pharmaceuticals Stock
Is Corvus Pharmaceuticals Stock a Buy?
-
Corvus Pharmaceuticals share price is 4.03 while CRVS 8-day simple moving average is 3.71, which is a Buy signal.
-
The stock price of CRVS is 4.03 while Corvus Pharmaceuticals 20-day SMA is 3.68, which makes it a Buy.
-
Corvus Pharmaceuticals 50-day simple moving average is 3.48 while CRVS share price is 4.03, making it a Buy technically.
-
CRVS stock price is 4.03 and Corvus Pharmaceuticals 200-day simple moving average is 5.29, creating a Sell signal.
CRVS Technical Analysis vs Fundamental Analysis
Sell
39
Corvus Pharmaceuticals (CRVS)
is a Sell
Is Corvus Pharmaceuticals a Buy or a Sell?
-
Corvus Pharmaceuticals stock is rated a SellThe current Corvus Pharmaceuticals [CRVS] share price is $4.03. The Score for CRVS is 39, which is 22% below its historic median score of 50, and infers higher risk than normal.
Corvus Pharmaceuticals Stock Info
Market Cap:
310.8M
Price in USD:
4.03
Share Volume:
807.1K
Corvus Pharmaceuticals 52-Week Range
52-Week High:
10.00
52-Week Low:
1.75
Sell
39
Corvus Pharmaceuticals (CRVS)
is a Sell
Corvus Pharmaceuticals Share Price Forecast
-
What is the Corvus Pharmaceuticals stock price today?The Corvus Pharmaceuticals stock price is 4.03 USD today.
-
Will CRVS stock go up or go down?Corvus Pharmaceuticals> share price is forecast to RISE/FALL based on technical indicators
-
Is Corvus Pharmaceuticals overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Corvus Pharmaceuticals is overvalued.
Is Corvus Pharmaceuticals Stock a Buy?
-
Corvus Pharmaceuticals share price is 4.03 while CRVS 8-day exponential moving average is 3.78, which is a Buy signal.
-
The stock price of CRVS is 4.03 while Corvus Pharmaceuticals 20-day EMA is 3.66, which makes it a Buy.
-
Corvus Pharmaceuticals 50-day exponential moving average is 3.11 while CRVS share price is 4.03, making it a Buy technically.
-
CRVS stock price is 4.03 and Corvus Pharmaceuticals 200-day simple moving average is 1.40, creating a Buy signal.
Fundamental Analysis of Corvus Pharmaceuticals
Is Corvus Pharmaceuticals a good investment?
-
Analysts estimate an earnings increase this quarter of $0.01 per share, a decrease next quarter of $0.01 per share, an increase this year of $0.67 per share, and a decrease next year of $0.30 per share.
Technical Analysis of Corvus Pharmaceuticals
Should I short Corvus Pharmaceuticals stock?
-
CRVS Moving Average Covergence Divergence (MACD) indicator is 0.16, suggesting Corvus Pharmaceuticals is a Buy
-
Corvus Pharmaceuticals Relative Strength Index (RSI) is 60.53, which suggest Corvus Pharmaceuticals is overbought
-
The Bollinger Bands (25) for Corvus Pharmaceuticals is (3.41 - 3.91), which suggest Corvus Pharmaceuticals is a Sell
-
The Bollinger Bands (100) for Corvus Pharmaceuticals is (3.34 - 5), which suggest Corvus Pharmaceuticals is a Sell
* Corvus Pharmaceuticals stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.